Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+71.6%
5Y CAGR+41.2%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+71.6%/yr
vs +10.4%/yr prior
5Y CAGR
+41.2%/yr
Recent acceleration
Acceleration
+61.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025111.88%
2024-351.04%
2023-62.00%
202222.14%
2021-25.45%
202019.94%
2019-130.78%
201814.89%
2017-29.86%
201624.16%